Carregant...
The Landscape of COVID-19 in Cancer Patients: Prevalence, Impacts, and Recommendations
Cancer patients are susceptible groups to COVID-19, and risk-adjusted models show that most cancer patients have a 25–39% mortality risk if infected with COVID-19. The infection rate of SARS-CoV-2 in cancer patients in China was 0.79% (12 of 1524 patients; 95% CI, 0.31.2%). The case fatality rate of...
Guardat en:
| Publicat a: | Cancer Manag Res |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7520115/ https://ncbi.nlm.nih.gov/pubmed/33061588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S272008 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|